Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms

Published:2014-12-02 Issue:50 Volume:111 Page:E5401-E5410
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Rampal Raajit,Ahn Jihae,Abdel-Wahab Omar,Nahas Michelle,Wang Kai,Lipson Doron,Otto Geoff A.,Yelensky Roman,Hricik Todd,McKenney Anna Sophia,Chiosis Gabriela,Chung Young Rock,Pandey Suveg,van den Brink Marcel R. M.,Armstrong Scott A.,Dogan Ahmet,Intlekofer Andrew,Manshouri Taghi,Park Christopher Y.,Verstovsek Srdan,Rapaport Franck,Stephens Philip J.,Miller Vincent A.,Levine Ross L.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. The Myeloproliferative Disorders

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

3. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

4. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

5. Identification of an Acquired JAK2 Mutation in Polycythemia Vera

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC7 is a potential therapeutic target in acute erythroid leukemia;Leukemia;2024-09-15

2. Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review;Hematology;2024-09-13

3. Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study;Annals of Hematology;2024-09-07

4. Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy;Clinical Lymphoma Myeloma and Leukemia;2024-09

5. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09